Development of Novel Gene Therapies for Treatment of Cardiomyopathy

Time: 8:30 am
day: Conference Day 1

Details:

  • Developing AAV gene therapies for various types of genetic cardiomyopathy
  • Using capsid engineering to discover novel AAVs with improved cardiac to liver transduction ratio
  • Optimising promoters and other cis-regulatory elements

Speakers: